pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-6077 |
Genomic Coordinates | chr1: 148388282 - 148388363 |
Description | Homo sapiens miR-6077 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-6077 | ||||||||||||||||||||||||
Sequence | 13| GGGAAGAGCUGUACGGCCUUC |33 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CALM3 | ||||||||||||||||||||
Synonyms | CaM, CaMIII, HEL-S-72, PHKD, PHKD3 | ||||||||||||||||||||
Description | calmodulin 3 | ||||||||||||||||||||
Transcript | NM_005184 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CALM3 | |||||||||||||||||||||
3'UTR of CALM3 (miRNA target sites are highlighted) |
>CALM3|NM_005184|3'UTR 1 AGGCCCCCCGGGCAGCTGGCGATGCCCGTTCTCTTGATCTCTCTCTTCTCGCGCGCGCACTCTCTCTTCAACACTCCCCT 81 GCGTACCCCGGTTCTAGCAAACACCAATTGATTGACTGAGAATCTGATAAAGCAACAAAAGATTTGTCCCAAGCTGCATG 161 ATTGCTCTTTCTCCTTCTTCCCTGAGTCTCTCTCCATGCCCCTCATCTCTTCCTTTTGCCCTCGCCTCTTCCATCCATGT 241 CTTCCAAGGCCTGATGCATTCATAAGTTGAAGCCCTCCCCAGATCCCCTTGGGGAGCCTCTGCCCTCCTCCAGCCCGGAT 321 GGCTCTCCTCCATTTTGGTTTGTTTCCTCTTGTTTGTCATCTTATTTTGGGTGCTGGGGTGGCTGCCAGCCCTGTCCCGG 401 GACCTGCTGGGAGGGACAAGAGGCCCTCCCCCAGGCAGAAGAGCATGCCCTTTGCCGTTGCATGCAACCAGCCCTGTGAT 481 TCCACGTGCAGATCCCAGCAGCCTGTTGGGGCAGGGGTGCCAAGAGAGGCATTCCAGAAGGACTGAGGGGGCGTTGAGGA 561 ATTGTGGCGTTGACTGGATGTGGCCCAGGAGGGGGTCGAGGGGGCCAACTCACAGAAGGGGACTGACAGTGGGCAACACT 641 CACATCCCACTGGCTGCTGTTCTGAAACCATCTGATTGGCTTTCTGAGGTTTGGCTGGGTGGGGACTGCTCATTTGGCCA 721 CTCTGCAAATTGGACTTGCCCGCGTTCCTGAAGCGCTCTCGAGCTGTTCTGTAAATACCTGGTGCTAACATCCCATGCCG 801 CTCCCTCCTCACGATGCACCCACCGCCCTGAGGGCCCGTCCTAGGAATGGATGTGGGGATGGTCGCTTTGTAATGTGCTG 881 GTTCTCTTTTTTTTTCTTTCCCCTCTATGGCCCTTAAGACTTTCATTTTGTTCAGAACCATGCTGGGCTAGCTAAAGGGT 961 GGGGAGAGGGAAGATGGGCCCCACCACGCTCTCAAGAGAACGCACCTGCAATAAAACAGTCTTGTCGGCCAGCTGCCCAG 1041 GGGACGGCAGCTACAGCAGCCTCTGCGTCCTGGTCCGCCAGCACCTCCCGCTTCTCCGTGGTGACTTGGCGCCGCTTCCT 1121 CACATCTGTGCTCCGTGCCCTCTTCCCTGCCTCTTCCCTCGCCCACCTGCCTGCCCCCATACTCCCCCAGCGGAGAGCAT 1201 GATCCGTGCCCTTGCTTCTGACTTTCGCCTCTGGGACAAGTAAGTCAATGTGGGCAGTTCAGTCGTCTGGGTTTTTTCCC 1281 CTTTTCTGTTCATTTCATCTGGCTCCCCCCACCACCTCCCCACCCCACCCCCCACCCCCTGCTTCCCCTCACTGCCCAGG 1361 TCGATCAAGTGGCTTTTCCTGGGACCTGCCCAGCTTTGAGAATCTCTTCTCATCCACCCTCTGGCACCCAGCCTCTGAGG 1441 GAAGGAGGGATGGGGCATAGTGGGAGACCCAGCCAAGAGCTGAGGGTAAGGGCAGGTAGGCGTGAGGCTGTGGACATTTT 1521 CGGAATGTTTTGGTTTTGTTTTTTTTAAACCGGGCAATATTGTGTTCAGTTCAAGCTGTGAAGAAAAATATATATCAATG 1601 TTTTCCAATAAAATACAGTGACTACCTGAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 808.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 808.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 5 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
Experimental Support 6 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
PAR-CLIP data was present in ERX177612. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_2
PAR-CLIP data was present in ERX177624. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_2
PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8
PAR-CLIP data was present in ERX177605. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_7
PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5
PAR-CLIP data was present in ERX177618. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_8
PAR-CLIP data was present in ERX177603. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_5
PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8
PAR-CLIP data was present in ERX177619. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_9
PAR-CLIP data was present in ERX177627. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_5
PAR-CLIP data was present in ERX177631. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_9
PAR-CLIP data was present in ERX177633. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_11
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000291295.9 | 3UTR | CCUCUUCCAUCCAUGUCUUCCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000291295.9 | 3UTR | CCUCUUCCAUCCAUGUCUUCCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000291295.9 | 3UTR | UCUCUCUCCAUGCCCCUCAUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000291295.9 | 3UTR | CCUCUUCCAUCCAUGUCUUCCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000291295.9 | 3UTR | CCUCUUCCAUCCAUGUCUUCCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000291295.9 | 3UTR | CCUCUUCCAUCCAUGUCUUCCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT060569 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT061579 | BTG2 | BTG anti-proliferation factor 2 | 2 | 4 | ||||||||
MIRT074383 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT079444 | FOXK2 | forkhead box K2 | 2 | 4 | ||||||||
MIRT082513 | CALM3 | calmodulin 3 | 2 | 10 | ||||||||
MIRT086211 | HOXD13 | homeobox D13 | 2 | 2 | ||||||||
MIRT097031 | MAP1B | microtubule associated protein 1B | 2 | 4 | ||||||||
MIRT119867 | NRBP1 | nuclear receptor binding protein 1 | 2 | 2 | ||||||||
MIRT124576 | PRRC2B | proline rich coiled-coil 2B | 2 | 2 | ||||||||
MIRT150043 | MIDN | midnolin | 2 | 4 | ||||||||
MIRT152597 | ZCCHC3 | zinc finger CCHC-type containing 3 | 2 | 6 | ||||||||
MIRT161909 | FXR1 | FMR1 autosomal homolog 1 | 2 | 2 | ||||||||
MIRT189355 | KPNA6 | karyopherin subunit alpha 6 | 2 | 2 | ||||||||
MIRT197844 | DCAF7 | DDB1 and CUL4 associated factor 7 | 2 | 2 | ||||||||
MIRT219933 | DNAJB9 | DnaJ heat shock protein family (Hsp40) member B9 | 2 | 2 | ||||||||
MIRT235611 | ASXL1 | additional sex combs like 1, transcriptional regulator | 2 | 2 | ||||||||
MIRT266233 | PEX11B | peroxisomal biogenesis factor 11 beta | 2 | 2 | ||||||||
MIRT266636 | CHTOP | chromatin target of PRMT1 | 2 | 2 | ||||||||
MIRT270563 | SETD1B | SET domain containing 1B | 2 | 2 | ||||||||
MIRT273829 | RPL41 | ribosomal protein L41 | 2 | 2 | ||||||||
MIRT309928 | RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 2 | 2 | ||||||||
MIRT342370 | PDIA3 | protein disulfide isomerase family A member 3 | 2 | 2 | ||||||||
MIRT369368 | SF3B3 | splicing factor 3b subunit 3 | 2 | 2 | ||||||||
MIRT375181 | ARIH1 | ariadne RBR E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT402071 | ATP6V1F | ATPase H+ transporting V1 subunit F | 2 | 4 | ||||||||
MIRT445016 | RBMS3 | RNA binding motif single stranded interacting protein 3 | 2 | 2 | ||||||||
MIRT445174 | TFPI | tissue factor pathway inhibitor | 2 | 2 | ||||||||
MIRT445453 | EXT1 | exostosin glycosyltransferase 1 | 2 | 2 | ||||||||
MIRT446601 | AKAP1 | A-kinase anchoring protein 1 | 2 | 2 | ||||||||
MIRT447806 | EMX1 | empty spiracles homeobox 1 | 2 | 2 | ||||||||
MIRT449827 | TLR4 | toll like receptor 4 | 2 | 2 | ||||||||
MIRT450678 | SEMA4F | ssemaphorin 4F | 2 | 2 | ||||||||
MIRT451774 | USP36 | ubiquitin specific peptidase 36 | 2 | 2 | ||||||||
MIRT451827 | ALDH3B1 | aldehyde dehydrogenase 3 family member B1 | 2 | 2 | ||||||||
MIRT452791 | FAM136A | family with sequence similarity 136 member A | 2 | 2 | ||||||||
MIRT453957 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT454413 | SEPT6 | septin 6 | 2 | 2 | ||||||||
MIRT454666 | FBXL18 | F-box and leucine rich repeat protein 18 | 2 | 2 | ||||||||
MIRT454734 | ARSK | arylsulfatase family member K | 2 | 2 | ||||||||
MIRT455329 | PLEKHM2 | pleckstrin homology and RUN domain containing M2 | 2 | 2 | ||||||||
MIRT455565 | TRAF1 | TNF receptor associated factor 1 | 2 | 2 | ||||||||
MIRT455733 | CDCA8 | cell division cycle associated 8 | 2 | 2 | ||||||||
MIRT455755 | YRDC | yrdC N6-threonylcarbamoyltransferase domain containing | 2 | 2 | ||||||||
MIRT456156 | TTF2 | transcription termination factor 2 | 2 | 2 | ||||||||
MIRT456629 | ARMCX6 | armadillo repeat containing, X-linked 6 | 2 | 2 | ||||||||
MIRT456684 | LDB1 | LIM domain binding 1 | 2 | 2 | ||||||||
MIRT457225 | AP3D1 | adaptor related protein complex 3 delta 1 subunit | 2 | 2 | ||||||||
MIRT457846 | RNASEH2B | ribonuclease H2 subunit B | 2 | 4 | ||||||||
MIRT457911 | ZNF212 | zinc finger protein 212 | 2 | 2 | ||||||||
MIRT459482 | CCL11 | C-C motif chemokine ligand 11 | 2 | 2 | ||||||||
MIRT459540 | AGAP1 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 | 2 | 2 | ||||||||
MIRT460002 | DNALI1 | dynein axonemal light intermediate chain 1 | 2 | 2 | ||||||||
MIRT460306 | FLCN | folliculin | 2 | 2 | ||||||||
MIRT460625 | IGFBP4 | insulin like growth factor binding protein 4 | 2 | 2 | ||||||||
MIRT460687 | RNF157 | ring finger protein 157 | 2 | 2 | ||||||||
MIRT460751 | FBLN5 | fibulin 5 | 2 | 2 | ||||||||
MIRT461028 | SDF4 | stromal cell derived factor 4 | 2 | 2 | ||||||||
MIRT462243 | PRSS16 | protease, serine 16 | 2 | 2 | ||||||||
MIRT462690 | SNRPD3 | small nuclear ribonucleoprotein D3 polypeptide | 2 | 2 | ||||||||
MIRT462872 | ZXDB | zinc finger, X-linked, duplicated B | 2 | 2 | ||||||||
MIRT463037 | ZNF689 | zinc finger protein 689 | 2 | 2 | ||||||||
MIRT463242 | ZIC5 | Zic family member 5 | 2 | 2 | ||||||||
MIRT463683 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 2 | 2 | ||||||||
MIRT463778 | YOD1 | YOD1 deubiquitinase | 2 | 2 | ||||||||
MIRT463914 | WNT3 | Wnt family member 3 | 2 | 2 | ||||||||
MIRT463949 | WIPF2 | WAS/WASL interacting protein family member 2 | 2 | 2 | ||||||||
MIRT464081 | VPS4A | vacuolar protein sorting 4 homolog A | 2 | 2 | ||||||||
MIRT465044 | TTC14 | tetratricopeptide repeat domain 14 | 2 | 2 | ||||||||
MIRT465330 | TPM3 | tropomyosin 3 | 2 | 2 | ||||||||
MIRT465657 | TNPO2 | transportin 2 | 2 | 2 | ||||||||
MIRT466490 | TEAD1 | TEA domain transcription factor 1 | 2 | 2 | ||||||||
MIRT467550 | SMARCD1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 2 | 4 | ||||||||
MIRT467770 | SLC2A4 | solute carrier family 2 member 4 | 2 | 2 | ||||||||
MIRT469007 | RNF41 | ring finger protein 41 | 2 | 2 | ||||||||
MIRT469032 | RNF38 | ring finger protein 38 | 2 | 6 | ||||||||
MIRT469757 | RAB2B | RAB2B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT469794 | RAB15 | RAB15, member RAS oncogene family | 2 | 2 | ||||||||
MIRT471159 | PHF12 | PHD finger protein 12 | 2 | 2 | ||||||||
MIRT471336 | PERP | PERP, TP53 apoptosis effector | 2 | 2 | ||||||||
MIRT471598 | PAQR5 | progestin and adipoQ receptor family member 5 | 2 | 8 | ||||||||
MIRT471899 | NUAK2 | NUAK family kinase 2 | 2 | 2 | ||||||||
MIRT471914 | NSUN4 | NOP2/Sun RNA methyltransferase family member 4 | 2 | 2 | ||||||||
MIRT471932 | NRAS | NRAS proto-oncogene, GTPase | 2 | 2 | ||||||||
MIRT472500 | NACC2 | NACC family member 2 | 2 | 2 | ||||||||
MIRT472746 | MTSS1L | MTSS1L, I-BAR domain containing | 2 | 2 | ||||||||
MIRT473098 | MLXIP | MLX interacting protein | 2 | 2 | ||||||||
MIRT473820 | MAP2K7 | mitogen-activated protein kinase kinase 7 | 2 | 2 | ||||||||
MIRT475423 | ICK | intestinal cell kinase | 2 | 2 | ||||||||
MIRT475649 | HIF3A | hypoxia inducible factor 3 alpha subunit | 2 | 4 | ||||||||
MIRT475761 | HDLBP | high density lipoprotein binding protein | 2 | 2 | ||||||||
MIRT476085 | GRB2 | growth factor receptor bound protein 2 | 2 | 2 | ||||||||
MIRT476605 | G3BP1 | G3BP stress granule assembly factor 1 | 2 | 2 | ||||||||
MIRT476784 | FOS | Fos proto-oncogene, AP-1 transcription factor subunit | 2 | 2 | ||||||||
MIRT477312 | EPHB2 | EPH receptor B2 | 2 | 2 | ||||||||
MIRT479075 | CNNM4 | cyclin and CBS domain divalent metal cation transport mediator 4 | 2 | 4 | ||||||||
MIRT479871 | CCDC6 | coiled-coil domain containing 6 | 2 | 2 | ||||||||
MIRT480028 | CANX | calnexin | 2 | 6 | ||||||||
MIRT480052 | CAND1 | cullin associated and neddylation dissociated 1 | 2 | 2 | ||||||||
MIRT480890 | BCL9L | B-cell CLL/lymphoma 9 like | 2 | 2 | ||||||||
MIRT480927 | BCAT1 | branched chain amino acid transaminase 1 | 2 | 4 | ||||||||
MIRT481448 | ARRB2 | arrestin beta 2 | 2 | 2 | ||||||||
MIRT482357 | AGO2 | argonaute 2, RISC catalytic component | 2 | 2 | ||||||||
MIRT483260 | CITED4 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4 | 2 | 4 | ||||||||
MIRT483434 | RHOXF2B | Rhox homeobox family member 2B | 2 | 2 | ||||||||
MIRT483843 | UNC5B | unc-5 netrin receptor B | 2 | 4 | ||||||||
MIRT484343 | EPN1 | epsin 1 | 2 | 4 | ||||||||
MIRT484707 | RNF11 | ring finger protein 11 | 2 | 4 | ||||||||
MIRT485705 | CBX7 | chromobox 7 | 2 | 2 | ||||||||
MIRT485947 | BRSK1 | BR serine/threonine kinase 1 | 2 | 2 | ||||||||
MIRT486528 | CLCN7 | chloride voltage-gated channel 7 | 2 | 2 | ||||||||
MIRT486692 | GLYR1 | glyoxylate reductase 1 homolog | 2 | 2 | ||||||||
MIRT487838 | CLSTN1 | calsyntenin 1 | 2 | 4 | ||||||||
MIRT487995 | RXRB | retinoid X receptor beta | 2 | 2 | ||||||||
MIRT488030 | ADO | 2-aminoethanethiol dioxygenase | 2 | 2 | ||||||||
MIRT488479 | B3GALNT2 | beta-1,3-N-acetylgalactosaminyltransferase 2 | 2 | 2 | ||||||||
MIRT488817 | TBC1D28 | TBC1 domain family member 28 | 2 | 2 | ||||||||
MIRT488884 | ASTN2 | astrotactin 2 | 2 | 4 | ||||||||
MIRT490493 | GLRA3 | glycine receptor alpha 3 | 2 | 2 | ||||||||
MIRT490878 | OSBP | oxysterol binding protein | 2 | 2 | ||||||||
MIRT490926 | GRIN2D | glutamate ionotropic receptor NMDA type subunit 2D | 2 | 4 | ||||||||
MIRT491036 | ALPK3 | alpha kinase 3 | 2 | 2 | ||||||||
MIRT491412 | SSPN | sarcospan | 2 | 4 | ||||||||
MIRT491583 | USB1 | U6 snRNA biogenesis phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT494037 | DUSP7 | dual specificity phosphatase 7 | 2 | 2 | ||||||||
MIRT495713 | PADI1 | peptidyl arginine deiminase 1 | 2 | 2 | ||||||||
MIRT498826 | DNTTIP2 | deoxynucleotidyltransferase terminal interacting protein 2 | 2 | 8 | ||||||||
MIRT498930 | TMEM106B | transmembrane protein 106B | 2 | 8 | ||||||||
MIRT499201 | TJAP1 | tight junction associated protein 1 | 2 | 2 | ||||||||
MIRT499586 | INTU | inturned planar cell polarity protein | 2 | 4 | ||||||||
MIRT499678 | MRE11A | MRE11 homolog, double strand break repair nuclease | 2 | 4 | ||||||||
MIRT499769 | SLC29A2 | solute carrier family 29 member 2 | 2 | 2 | ||||||||
MIRT500120 | ZNF106 | zinc finger protein 106 | 2 | 4 | ||||||||
MIRT501739 | NSD1 | nuclear receptor binding SET domain protein 1 | 2 | 2 | ||||||||
MIRT503315 | FICD | FIC domain containing | 2 | 4 | ||||||||
MIRT503449 | PNMA2 | paraneoplastic Ma antigen 2 | 2 | 6 | ||||||||
MIRT507136 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 2 | ||||||||
MIRT511906 | FKBP1A | FK506 binding protein 1A | 2 | 2 | ||||||||
MIRT513103 | DYNAP | dynactin associated protein | 2 | 2 | ||||||||
MIRT520500 | TRAM2 | translocation associated membrane protein 2 | 2 | 6 | ||||||||
MIRT524337 | CRIM1 | cysteine rich transmembrane BMP regulator 1 | 2 | 6 | ||||||||
MIRT525321 | SNX29 | sorting nexin 29 | 2 | 2 | ||||||||
MIRT526804 | TANGO2 | transport and golgi organization 2 homolog | 2 | 2 | ||||||||
MIRT530935 | ENPP6 | ectonucleotide pyrophosphatase/phosphodiesterase 6 | 2 | 2 | ||||||||
MIRT537471 | FAM63B | MINDY lysine 48 deubiquitinase 2 | 2 | 2 | ||||||||
MIRT538696 | CASP16 | caspase 16, pseudogene | 2 | 4 | ||||||||
MIRT541101 | RAF1 | Raf-1 proto-oncogene, serine/threonine kinase | 2 | 2 | ||||||||
MIRT545632 | GGCX | gamma-glutamyl carboxylase | 2 | 2 | ||||||||
MIRT545660 | TMEM97 | transmembrane protein 97 | 2 | 4 | ||||||||
MIRT545919 | ZC3H4 | zinc finger CCCH-type containing 4 | 2 | 2 | ||||||||
MIRT546411 | SPRED3 | sprouty related EVH1 domain containing 3 | 2 | 2 | ||||||||
MIRT546520 | SERTAD3 | SERTA domain containing 3 | 2 | 2 | ||||||||
MIRT547205 | PARP1 | poly(ADP-ribose) polymerase 1 | 2 | 2 | ||||||||
MIRT548142 | FYCO1 | FYVE and coiled-coil domain containing 1 | 2 | 2 | ||||||||
MIRT548961 | CCNT2 | cyclin T2 | 2 | 2 | ||||||||
MIRT549400 | AKAP11 | A-kinase anchoring protein 11 | 2 | 2 | ||||||||
MIRT551661 | KIAA1143 | KIAA1143 | 2 | 4 | ||||||||
MIRT552470 | ZNF275 | zinc finger protein 275 | 2 | 4 | ||||||||
MIRT557120 | HOXA3 | homeobox A3 | 2 | 2 | ||||||||
MIRT557324 | HIATL1 | major facilitator superfamily domain containing 14B | 2 | 4 | ||||||||
MIRT557442 | GTPBP2 | GTP binding protein 2 | 2 | 2 | ||||||||
MIRT557680 | GATA6 | GATA binding protein 6 | 2 | 2 | ||||||||
MIRT559844 | RBM23 | RNA binding motif protein 23 | 2 | 2 | ||||||||
MIRT559872 | ATXN3 | ataxin 3 | 2 | 2 | ||||||||
MIRT559929 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT559977 | RELA | RELA proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT560091 | ERCC8 | ERCC excision repair 8, CSA ubiquitin ligase complex subunit | 2 | 2 | ||||||||
MIRT560103 | ZNF557 | zinc finger protein 557 | 2 | 2 | ||||||||
MIRT560118 | RAB6C | RAB6C, member RAS oncogene family | 2 | 2 | ||||||||
MIRT560126 | PRDM6 | PR/SET domain 6 | 2 | 2 | ||||||||
MIRT560175 | COA1 | cytochrome c oxidase assembly factor 1 homolog | 2 | 2 | ||||||||
MIRT560261 | TMEM236 | transmembrane protein 236 | 2 | 2 | ||||||||
MIRT560311 | EFHD2 | EF-hand domain family member D2 | 2 | 2 | ||||||||
MIRT560372 | TAF8 | TATA-box binding protein associated factor 8 | 2 | 2 | ||||||||
MIRT560425 | ANGPTL3 | angiopoietin like 3 | 2 | 2 | ||||||||
MIRT560467 | SMIM9 | small integral membrane protein 9 | 2 | 2 | ||||||||
MIRT560471 | ENSA | endosulfine alpha | 2 | 2 | ||||||||
MIRT560496 | KCNJ10 | potassium voltage-gated channel subfamily J member 10 | 2 | 2 | ||||||||
MIRT560509 | POGK | pogo transposable element derived with KRAB domain | 2 | 2 | ||||||||
MIRT560554 | SIGLEC14 | sialic acid binding Ig like lectin 14 | 2 | 2 | ||||||||
MIRT560560 | MYLK | myosin light chain kinase | 2 | 2 | ||||||||
MIRT560593 | FAM114A1 | family with sequence similarity 114 member A1 | 2 | 2 | ||||||||
MIRT560610 | TRIM38 | tripartite motif containing 38 | 2 | 2 | ||||||||
MIRT560615 | ANKRD36 | ankyrin repeat domain 36 | 2 | 2 | ||||||||
MIRT560808 | PPIP5K2 | diphosphoinositol pentakisphosphate kinase 2 | 2 | 2 | ||||||||
MIRT560888 | SULT1B1 | sulfotransferase family 1B member 1 | 2 | 2 | ||||||||
MIRT560914 | PA2G4 | proliferation-associated 2G4 | 2 | 2 | ||||||||
MIRT560949 | POTED | POTE ankyrin domain family member D | 2 | 2 | ||||||||
MIRT560958 | WRN | Werner syndrome RecQ like helicase | 2 | 2 | ||||||||
MIRT561001 | C8orf37 | chromosome 8 open reading frame 37 | 2 | 2 | ||||||||
MIRT561080 | LLPH | LLP homolog, long-term synaptic facilitation | 2 | 2 | ||||||||
MIRT561104 | OPA3 | OPA3, outer mitochondrial membrane lipid metabolism regulator | 2 | 2 | ||||||||
MIRT561198 | LDHD | lactate dehydrogenase D | 2 | 2 | ||||||||
MIRT561207 | ZXDA | zinc finger, X-linked, duplicated A | 2 | 2 | ||||||||
MIRT561286 | ZCCHC14 | zinc finger CCHC-type containing 14 | 2 | 2 | ||||||||
MIRT561370 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT561488 | SUPT16H | SPT16 homolog, facilitates chromatin remodeling subunit | 2 | 2 | ||||||||
MIRT561516 | SPTY2D1 | SPT2 chromatin protein domain containing 1 | 2 | 2 | ||||||||
MIRT561677 | RAD54L2 | RAD54 like 2 | 2 | 2 | ||||||||
MIRT561838 | NREP | neuronal regeneration related protein | 2 | 2 | ||||||||
MIRT561959 | LSM12 | LSM12 homolog | 2 | 2 | ||||||||
MIRT562342 | EXOSC2 | exosome component 2 | 2 | 2 | ||||||||
MIRT562386 | EN2 | engrailed homeobox 2 | 2 | 2 | ||||||||
MIRT562399 | EIF4E | eukaryotic translation initiation factor 4E | 2 | 2 | ||||||||
MIRT562477 | CHORDC1 | cysteine and histidine rich domain containing 1 | 2 | 2 | ||||||||
MIRT563631 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT563991 | SLFN11 | schlafen family member 11 | 2 | 2 | ||||||||
MIRT564294 | MED26 | mediator complex subunit 26 | 2 | 2 | ||||||||
MIRT565594 | SLC35G1 | solute carrier family 35 member G1 | 2 | 2 | ||||||||
MIRT567200 | IGFBP5 | insulin like growth factor binding protein 5 | 2 | 4 | ||||||||
MIRT567410 | GOLPH3L | golgi phosphoprotein 3 like | 2 | 2 | ||||||||
MIRT568367 | ATXN1 | ataxin 1 | 2 | 2 | ||||||||
MIRT569870 | KLK10 | kallikrein related peptidase 10 | 2 | 2 | ||||||||
MIRT571258 | LSM3 | LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated | 2 | 2 | ||||||||
MIRT571688 | RPRD2 | regulation of nuclear pre-mRNA domain containing 2 | 2 | 2 | ||||||||
MIRT572702 | SRPK1 | SRSF protein kinase 1 | 2 | 2 | ||||||||
MIRT573931 | CNTNAP2 | contactin associated protein like 2 | 2 | 2 | ||||||||
MIRT573965 | LINGO1 | leucine rich repeat and Ig domain containing 1 | 2 | 2 | ||||||||
MIRT618154 | CHCHD5 | coiled-coil-helix-coiled-coil-helix domain containing 5 | 2 | 2 | ||||||||
MIRT619123 | CD40LG | CD40 ligand | 2 | 2 | ||||||||
MIRT620228 | PACS1 | phosphofurin acidic cluster sorting protein 1 | 2 | 2 | ||||||||
MIRT640243 | DERL2 | derlin 2 | 2 | 2 | ||||||||
MIRT652912 | SYNPO2L | synaptopodin 2 like | 2 | 2 | ||||||||
MIRT661918 | EBNA1BP2 | EBNA1 binding protein 2 | 2 | 2 | ||||||||
MIRT697846 | UBE2Z | ubiquitin conjugating enzyme E2 Z | 2 | 2 | ||||||||
MIRT701989 | MIER3 | MIER family member 3 | 2 | 2 | ||||||||
MIRT702213 | LPCAT1 | lysophosphatidylcholine acyltransferase 1 | 2 | 2 | ||||||||
MIRT705575 | ARHGEF12 | Rho guanine nucleotide exchange factor 12 | 2 | 2 | ||||||||
MIRT708500 | FAM9C | family with sequence similarity 9 member C | 2 | 2 | ||||||||
MIRT716273 | NUP85 | nucleoporin 85 | 2 | 2 | ||||||||
MIRT723698 | CKS2 | CDC28 protein kinase regulatory subunit 2 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|